In vitro effect of hydroxyethyl starch on COVID-19 patients-associated hypofibrinolytic state
Description
CONCLUSION: These results highlight that HES increased apparent in vitro tPA-induced fibrinolysis in case of severe COVID-19 disease. Use of this plasma volume expander may translate as a potential help against COVID-19-induced thrombosis occurrence.
